Kopran Limited (NSE:KOPRAN)
India · Delayed Price · Currency is INR 182.12
-2.64 (-1.43%)
Sep 10, 2025, 3:29 PM IST
Kopran Market Cap
Kopran has a market cap or net worth of 8.80 billion as of September 10, 2025. Its market cap has decreased by -42.24% in one year.
Market Cap
8.80B
Enterprise Value
10.02B
Revenue
6.25B
Ranking
n/a
PE Ratio
25.21
Stock Price
182.12
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 8.80B, an increase of 1,438.47%. That is a compound annual growth rate of 12.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 8.91B | -13.01% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | 6.02B | 345.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,819.02B |
| Divi's Laboratories | 1,593.48B |
| Cipla | 1,253.31B |
| Apollo Hospitals Enterprise | 1,125.19B |
| Mankind Pharma | 1,068.76B |
| Zydus Lifesciences | 1,042.06B |
| Fortis Healthcare | 716.91B |
| Alkem Laboratories | 638.00B |